Heparin inhibition of polymorphonuclear leukocyte activation in vitro. A possible pharmacological approach to granulocyte-mediated vascular damage.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Thrombosis Research

• Publication date

  1984-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0049-3848(84)90284-6PMID 6091291
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Inhibitory Effect of Heparin and Related Glycosaminoglycans on Neutrophil Chemotaxis

  1984cited by this paper
• Synergistic effect of heparin and chemotactic factor on polymorphonuclear leukocyte aggregation and degranulation.

  1983cited by this paper
• Effect of calcium/sodium heparin and heparin fractions on some functions of human polymor phonuclear receptors

  1982cited by this paper
• Cholesterol and atheroma lipids activate complement and stimulate granulocytes. A possible mechanism for amplification of ischemic injury in atherosclerotic states.

  1981cited by this paper
• Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells.

  1981cited by this paper
• Heparin inhibits phagocytosis by polymorphonuclear leukocytes

  1981cited by this paper
• Complement-induced granulocyte aggregation in vivo.

  1981cited by this paper
• Release of inflammatory mediators from stimulated neutrophils.

  1980cited by this paper
• The free radical pathology and the microcirculation in the major central nervous system disorders.

  1980cited by this paper
• Inhibition of Rat Arterial Smooth Muscle Cell Proliferation by Heparin: In Vivo Studies with Anticoagulant and Nonanticoagulant Heparin

  1980cited by this paper
• Oxygen metabolism and the toxic properties of phagocytes.

  1980cited by this paper
• Regulation of granulocyte function by hyaluronic acid. In vitro and in vivo effects on phagocytosis, locomotion, and metabolism.

  1980cited by this paper
• Inhibition of Rat Arterial Smooth Muscle Cell Proliferation by Heparin: II. In Vitro Studies

  1980cited by this paper
• Dietary induced atherogenesis in swine. Morphology of the intima in prelesion stages.

  1979cited by this paper
• Granulocyte aggregation as a manifestation of membrane interactions with complement: possible role in leukocyte margination, microvascular occlusion, and endothelial damage.

  1979cited by this paper
• Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.

  1978cited by this paper
• Oxygen-dependent microbial killing by phagocytes (second of two parts).

  1978cited by this paper
• Oxygen-dependent microbial killing by phagocytes (first of two parts).

  1978cited by this paper
• Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.

  1977cited by this paper
• Endothelial cell injury in early mild hypercholesterolemia.

  1977cited by this paper
• Polymorphonuclear Leukocyte lysosomes and immune tissue injury.

  1976cited by this paper
• Polymorphonuclear Leukocyte Lysosomes and Immune Tissue Injury (Part 1 of 2)

  1976cited by this paper
• Deposition of formed elements of blood on the intima and signs of intimal injury in the aorta of rabbit, pig, and man.

  1972cited by this paper
• Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity.

  1972cited by this paper

• Heparin, Heparan Sulphate and Sepsis: Potential New Options for Treatment

  2023cites this paper
• Physiological Roles of Mast Cells: Collegium Internationale Allergologicum Update 2019

  2019cites this paper
• Low molecular weight heparins prevent the induction of autophagy of activated neutrophils and the formation of neutrophil extracellular traps

  2017cites this paper
• Pharmacology of Heparin and Related Drugs

  2016cites this paper
• heparins on allergic airway responses Molecular-weight-dependent effects of nonanticoagulant

  2015cites this paper
• Protective role of heparin in the injury of the liver and kidney on the experimental model of ischemia/reperfusion

  2014cites this paper
• Heparin-derived supersulfated disaccharide inhibits allergic airway responses in sheep.

  2014cites this paper
• Effect of oral and intravenous heparin tetrasaccharide on allergic airway responses: critical role of N-sulfation.

  2013cites this paper
• Heparin and Related Drugs: Beyond Anticoagulant Activity

  2013cites this paper
• Non-anticoagulant effects of heparin: an overview.

  2012cites this paper
• Heparin - A Century of Progress

  2012cites this paper
• Chitosan derivatives as novel potential heparin reversal agents.

  2010cites this paper
• Healing effect of heparin in the course of acute cerulein-induced pancreatitis Leczniczy efekt heparyny w przebiegu ostrego zapalenia trzustki wywo³anego cerulein¹

  2009cites this paper
• Anti-inflammatory properties of a heparin-like glycosaminoglycan with reduced anti-coagulant activity isolated from a marine shrimp.

  2008cites this paper
• Protective and therapeutic effect of heparin in acute pancreatitis.

  2008cites this paper
• Targeting Polymorphonuclear Leukocytes in Acute Myocardial Infarction

  2007cites this paper
• Issues regarding the use of heparin following streptokinase therapy

  2005cites this paper
• Pharmacodynamics of ticlopidine in man in relation to plasma and blood cell concentration

  2004cites this paper
• Comparison of the antioxidant properties of wound dressing materials--carboxymethylcellulose, hyaluronan benzyl ester and hyaluronan, towards polymorphonuclear leukocyte-derived reactive oxygen species.

  2003cites this paper
• N-desulfated non-anticoagulant heparin inhibits leukocyte adhesion and transmigration in vitro and attenuates acute peritonitis and ischemia and reperfusion injury in vivo

  2002cites this paper
• Oxidative stress during hemodialysis: effect of heparin.

  2001cites this paper
• Heparin and the nonanticoagulant N-acetyl heparin attenuate capillary no-reflow after normothermic ischemia of the lung.

  2001cites this paper
• Effect of heparin on apoptosis in human nasopharyngeal carcinoma CNE2 cells

  2001cites this paper
• Inhibition of allergic late airway responses by inhaled heparin-derived oligosaccharides.

  2000cites this paper
• Inhibition of glomerular cell apoptosis by heparin.

  1999cites this paper
• The concept of glomerular self-defense.

  1999cites this paper
• Molecular-weight-dependent effects of nonanticoagulant heparins on allergic airway responses.

  1999cites this paper
• Anticoagulant therapy in unstable angina.

  1999cites this paper
• Heparin in inflammation: potential therapeutic applications beyond anticoagulation.

  1999cites this paper
• Vascular heparan sulfates may limit the ability of leukocytes to penetrate the endothelial barrier--implications for use of glucosamine in inflammatory disorders.

  1998cites this paper
• Dextran sulfate inhibits E-selectin-mediated neutrophil adhesion to endotoxin-activated vascular endothelial cells.

  1998cites this paper
• Heparin and nonanticoagulant heparin preserve regional myocardial contractility after ischemia-reperfusion injury: role of nitric oxide.

  1998cites this paper
• Heparin preserves nitric oxide activity in coronary endothelium during ischemia-reperfusion injury.

  1998cites this paper
• Is Heparin of Value in the Management of Acute Myocardial Infarction?

  1997cites this paper
• Reduction of Myocardial Necrosis after Glycosaminoglycan Administration: Effects of a Single Intravenous Administration of Heparin or N-Acetylheparin 2 Hours before Regional Ischemia and Reperfusion

  1996cites this paper
• Heparin-like glycosaminoglycans inhibit leukocyte adhesion to endotoxin-activated human vascular endothelial cells under nonstatic conditions.

  1996cites this paper
• Heparins for proliferative nephritides? Short review on an advancing topic.

  1996cites this paper
• Low molecular weight heparins: a valuable tool in the treatment of acute coronary syndromes.

  1996cites this paper
• The Effect of Low Molecular Weight Heparin (Fragmin) on Myocardial Neutrophil Accumulation and Infarct Size in a Rat Model of Myocardial Infarction

  1996cites this paper
• Biocompatibility of sulphonated polyurethane surfaces.

  1996cites this paper
• Heparin effects on superoxide production by neutrophils.

  1995cites this paper
• Role of neutrophils in myocardial ischemia and reperfusion.

  1995cites this paper
• Cardioprotective effects of heparin or N-acetylheparin in an in vivo model of myocardial ischaemic and reperfusion injury.

  1995cites this paper
• Subcutaneous, catheter-related inflammation in a rabbit model correlates with peripheral vein phlebitis in human volunteers.

  1994cites this paper
• Effects of heparin and N-acetyl heparin on ischemia/reperfusion-induced alterations in myocardial function in the rabbit isolated heart.

  1994cites this paper
• The non-antithrombotic therapeutic potential of heparin and related heparinoids in cardiovascular diseases.

  1994cites this paper
• Effect of thrombosis on complement activation and neutrophil degranulation during in vitro hemodialysis.

  1994cites this paper
• Interaction Between Glycosaminoglycans, Platelets, and Leukocytes

  1994cites this paper
• Neutrophils may contribute to the morbidity and mortality of claudicants

  1994cites this paper
• Nursing implications of low-dose heparin to infusate to improve infusion site survival in children.

  1993cites this paper
• The effects of high molecular weight- and low molecular weight-heparins on superoxide ion production and degranulation by human polymorphonuclear leukocytes.

  1993cites this paper
• Effects of glycosaminoglycans on platelet and leucocyte function: role of N-sulfation.

  1993cites this paper
• Effect of heparin, dermatan sulfate, and related oligo-derivatives on human polymorphonuclear leukocyte functions.

  1993cites this paper
• Effects of Heparin on the Vessel Wall and Blood Cellular Elements

  1993cites this paper
• Inhibition of neutrophil function in vitro by heparan sulfate.

  1993cites this paper
• WEB 2086 inhibits neutrophil dependent increases in coronary resistance in blood perfused rabbit heart.

  1992cites this paper
• Anti-inflammatory effects of heparin and its derivatives: inhibition of complement and of lymphocyte migration.

  1992cites this paper
• Influence of Selected Heparins on Human Neutrophil Functions In Vitro

  1992cites this paper
• Specific binding between human neutrophils and heparin

  1992cites this paper
• Therapeutic potential of vitamin E in the pathogenesis of spontaneous atherosclerosis.

  1991cites this paper
• Effect of cefodizime (HR 221) on immunological defects induced by surgical stress.

  1991cites this paper
• Defibrotide Inhibits Ca2+ Dependent Neutrophil Activation: Implications for its Pharmacological Activity in Vascular Disorders

  1991cites this paper
• Whole blood granulocyte aggregation in vitro in dialysis-dependent patients.

  1991cites this paper
• The white blood cell as a risk factor for thrombotic vascular disease

  1990cites this paper
• Captopril: a free radical scavenger.

  1989cites this paper
• FREE RADICALS AND GRAVES' DISEASE: THE EFFECTS OF THERAPY

  1989cites this paper
• Free radical pathology in chronic arterial disease.

  1989cites this paper
• In Vivo and in Vitro Evidence of an Adenosine-Mediated Mechanism of Calcium Entry Blocker Activities

  1989cites this paper
• Update on the relationship of heparin to atherosclerosis and its thrombotic complications.

  1988cites this paper
• Pharmacological Basis and Therapeutic Efficacy of Flunarizine in Peripheral Artery Disease

  1988cites this paper
• Effect of defibrotide on polymorphonuclear leukocytes: modulation of calcium entry and availability.

  1988cites this paper
• Inhibition of leucocyte elastase by heparin and its derivatives.

  1988cites this paper
• Indomethacin, prostacyclin, and heparin improve postischemic cerebral blood flow without affecting early postischemic granulocyte accumulation.

  1987cites this paper
• Defibrotide in vitro inhibits neutrophil activation by a Ca++-involving mechanism.

  1987cites this paper
• Hemorheological Changes in Elderly Subjects-Effect of Pentosan Polysulfate and Possible Role of Leucocyte Arachidonic Acid Metabolism

  1987cites this paper
• Benzodiazepines inhibit in vitro free radical formation from human neutrophils induced by FMLP and A23187.

  1987cites this paper
• In vitro evaluation of heparin fractions: old vs. new methods.

  1986cites this paper
• Adenosine inhibits polymorphonuclear leukocyte in vitro activation: a possible role as an endogenous calcium entry blocker.

  1985cites this paper
• Inhibition of mouse natural killer cytotoxicity by heparin.

  1985cites this paper
• Heparin: applications and future prospects.

  1985cites this paper